CareDx, Inc. (CDNA)

Slide locked Sign in to view

Slide schematic 7/9

callout 0/1 paragraph 4/4 quote 1/2 source-note 2/2

2 without position callout 1 · quote 1

calloutquote

Components 9

callout paragraph paragraph paragraph paragraph pull-quote quote source-note source-note

Tools 1

Narrative foundations (from the Storymakers methodology) slide · 50%

The idea of quantifying the proportion of dd-cfDNA as a marker of kidney injury was first hypothesized in the late 1990's by Dennis Lo and his team at the Chinese University of Hong Kong.

Metrics 0

∅

No metrics

No metric insight is anchored to this slide.

Frameworks 0

∅

No frameworks

No framework match is anchored to this slide.

Find anything

The slide provides a critical narrative on the efficacy of dd-cfDNA testing, highlighting the gap between academic hope and clinical utility.